Author

Srivani Ajmera

Observed names: Ajmera, S, S Ajmera, S. AJMERA

Observed institutions: Howard Hughes Medical Institute, University of Michigan

ORCID: 0000-0002-1011-1674

Observed ORCID: 0000-0002-1011-1674

OpenAlex ID: A5036933836

A Cloned Human DNA Restriction Fragment Determines Expression of a GDP-L-fucose:β-D-Galactoside 2-α-L-fucosytransferase in Transfected Cells

1989 · V P Rajan, R D Larsen, et al. · Journal of Biological Chemistry · 109

Quality by Design Approach for Preparation, Characterization, and Statistical Optimization of Naproxen Sodium-loaded Ethosomes via Transdermal Route

2023 · Ananda Kumar Chettupalli, Srivani Ajmera, et al. · Current Bioactive Compounds · 18

Effects of incorporation of 6-thioguanine into SV40 DNA.

1987 · J Maybaum, A N Bainnson, et al. · Molecular Pharmacology · 17

Design Formulation of Nanospanlastic Novel Carriers as a Promising Approach to Enhanced Bioavailability in Intranasal Drug Delivery for Sinusitis: Statistical Optimization and In vitro and In vivo Characterization

2024 · Ananda Kumar Chettupalli, Srivani Ajmera, et al. · Current Nanomedicine · 8

ChemInform Abstract: SYNTHESIS AND BIOLOGICAL ACTIVITY OF 5‐FLUORO‐2′,3′‐DIDEOXY‐3′‐FLUOROURIDINE AND ITS 5′‐PHOSPHATE

1984 · S. AJMERA, A. R. BAPAT, et al. · ChemInform

ChemInform Abstract: Synthesis and Biological Activity of 5′‐Substituted S‐Fluoropyrimidine Nucleosides.

1983 · S. AJMERA, P. V. DANENBERG · ChemInform

Antitumor activity of 5'-deoxy-5'-substituted-5-fluorouri- dine derivatives. Abstr.

1982 · Ajmera, S, Danenberg, P V · The Mouseion at the JAXlibrary (Jackson Laboratory)

Works count: 7

Citation count: 152

H-index: 4

I10-index: 3